Additionally, it was suggested that Isg15 may serve as a potential bridge between type I (IFN-α, IFN-β) and type II (IFN-γ) IFN-mediated immune responses, which are both known to be implicated in SLE pathogenesis [20, 50]. This evidence concerns the gene IFNA1 and systemic lupus erythematosus.